Xilio Therapeutics (XLO) Earnings Date, Estimates & Call Transcripts $0.74 -0.01 (-1.39%) Closing price 03:59 PM EasternExtended Trading$0.74 +0.00 (+0.03%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xilio Therapeutics Earnings Summary Upcoming Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Mar. 11) -$0.22 Actual EPS (Mar. 11) -$0.20 Beat By $0.02 Actual Revenue (Mar. 11) $1.72MXilio Therapeutics posted Q4 2024 earnings on March 11, 2025, reporting an EPS of -$0.20, which topped the consensus estimate of -$0.22 by $0.02. Quarterly revenue was reported to be $1.72 million, below the consensus estimate of $2.26 million. With a trailing EPS of -$1.28, Xilio Therapeutics' earnings are expected to grow next year, from ($1.14) to ($0.40) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)XLO Upcoming EarningsXilio Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled on Friday, May 16, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Xilio Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xilio Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataXLO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XLO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Xilio Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.14) EPSNext Year EPS Consensus Estimate ($0.40) EPS Xilio Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)--------3/11/2025Q4 2024-$0.22-$0.20+$0.02-$0.20$2.26M$1.72M11/7/2024--$0.25-$0.22+$0.03-$0.22--8/8/2024--$0.23-$0.24 -$0.01-$0.24$30.00M$2.36M5/14/2024Q1 2024-$0.30-$0.59 -$0.29-$0.56--4/1/2024Q4 2023--$0.64 -$0.64-$0.64--11/9/2023Q3 2023-$0.76-$0.61+$0.15-$0.61--8/14/2023Q2 2023-$0.84-$0.70+$0.14-$0.70--5/9/2023Q1 2023-$0.91-$0.83+$0.08-$0.83-- Xilio Therapeutics Earnings - Frequently Asked Questions When is Xilio Therapeutics's earnings date? Xilio Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on XLO's earnings history. Did Xilio Therapeutics beat their earnings estimates last quarter? In the previous quarter, Xilio Therapeutics (NASDAQ:XLO) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.02. Learn more on analysts' earnings estimate vs. XLO's actual earnings. How much revenue does Xilio Therapeutics generate each year? Xilio Therapeutics (NASDAQ:XLO) has a recorded annual revenue of $6.34 million. How much profit does Xilio Therapeutics generate each year? Xilio Therapeutics (NASDAQ:XLO) has a recorded net income of -$76.40 million. XLO has generated -$1.28 earnings per share over the last four quarters. What is Xilio Therapeutics's EPS forecast for next year? Xilio Therapeutics's earnings are expected to grow from ($1.14) per share to ($0.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies ProQR Therapeutics Earnings Results Tango Therapeutics Earnings Results 4D Molecular Therapeutics Earnings Results LifeVantage Earnings Results Larimar Therapeutics Earnings Results Puma Biotechnology Earnings Results Cybin Earnings Results Aclaris Therapeutics Earnings Results Eupraxia Pharmaceuticals Earnings Results ADC Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:XLO) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XLO Stock Free XLO Stock Alerts